GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pila Pharma AB (OSTO:PILA) » Definitions » Total Equity

Pila Pharma AB (OSTO:PILA) Total Equity : kr5.26 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Pila Pharma AB Total Equity?

Pila Pharma AB's total equity for the quarter that ended in Dec. 2024 was kr5.26 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Pila Pharma AB Total Equity Historical Data

The historical data trend for Pila Pharma AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pila Pharma AB Total Equity Chart

Pila Pharma AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial 3.42 30.30 9.53 6.66 5.26

Pila Pharma AB Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.43 0.90 6.66 2.58 5.26

Pila Pharma AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Pila Pharma AB's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=6.224-0.963
=5.26

Pila Pharma AB's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=6.224-0.963
=5.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pila Pharma AB Total Equity Related Terms

Thank you for viewing the detailed overview of Pila Pharma AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Pila Pharma AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pila Pharma AB (OSTO:PILA) » Definitions » Total Equity
Comparable Companies
XSAT:ABERA OSTO:BIOSGN OSTO:SPAGO OSTO:SIMRIS B OSTO:BIOVIC B OSTO:ONCOZ XSAT:DEX OSTO:ELIC XSAT:NIDHOG XSAT:BIOWKS VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
5KC:Germany
Address
Norra Vallgatan 72, Malmo, SWE, 211 21
Website
https://www.pilapharma.com
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.

Pila Pharma AB Headlines

No Headlines